Innodem Neurosciences

Innodem Neurosciences is a digital biomarker & AI company that specializes in the development of an eye tracking technology, ETNA™, that shows promising use for neurological assessment of the progression of various neurodegenerative and mental diseases. The ETNA™ technology is being trialed with patients living with various neurodegenerative and mental diseases, such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, Friedreich Ataxia, and cancer-related cognitive impairment. Its patented ETNA™-MS technology is currently under regulatory review.

57.6logo
logo
logo
logo
logo
logo
57.6
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logologologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 6.00 M
$ 6.76 M
Funding
$ 6.00 M
$ 6.76 M
Statistics
logo
NA
Action

Innodem Neurosciences is a digital biomarker & AI company that specializes in the development of an eye tracking technology, ETNA™, that shows promising use for neurological assessment of the progression of various neurodegenerative and mental diseases. The ETNA™ technology is being trialed with patients living with various neurodegenerative and mental diseases, such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, Friedreich Ataxia, and cancer-related cognitive impairment. Its patented ETNA™-MS technology is currently under regulatory review.

0and0